The Japan diagnostic labs market was valued at USD 15.38 Billion in 2025 and is expected to grow at a CAGR of 6.10%, reaching USD 27.80 Billion by 2035. The market growth is driven by an aging population, focus on preventive healthcare, and increasing government spending on medical diagnostics.
Base Year
Historical Period
Forecast Period
The market is expanding due to its aging population, which increases the demand for early detection of chronic diseases like cancer and diabetes. Technological advancements, including AI integration and non-invasive testing methods, further propel this growth.
The market is witnessing a surge in molecular diagnostics and point-of-care testing, enhancing rapid and accurate disease detection. Additionally, the integration of digital health technologies is transforming diagnostic services, making them more accessible and efficient.
Strategic partnerships and continuous innovation are key strategies the key players employ to maintain competitiveness and drive Japan diagnostic labs market growth.
Compound Annual Growth Rate
6.1%
Value in USD Billion
2026-2035
*this image is indicative*
Diagnostic laboratories are specialized healthcare facilities that conduct a wide range of tests on clinical specimens such as blood, urine, and tissue to provide critical information for disease detection, accurate diagnosis, effective treatment planning, and ongoing health monitoring. The diagnostic laboratories market in Japan is witnessing notable expansion due to factors such as a rapidly aging population, advancements in diagnostic technologies, and a growing emphasis on preventive healthcare.
Rising Chronic Disease Prevalence to Drive the Market Growth
The rising prevalence of chronic diseases, particularly among the aging population are significantly boosting market growth. According to a 2023 study by Seigo Mitsutake et al., over 90% of Japanese adults aged 75 and older are affected by at least one chronic condition, while approximately 80% live with multiple chronic illnesses. This significant disease burden underscores the growing need for frequent, accurate, and comprehensive diagnostic testing to facilitate early detection, ongoing monitoring, and effective disease management. As chronic illnesses such as diabetes, cardiovascular disease, and cancer continue to rise, there is a corresponding increase in demand for advanced laboratory services and diagnostic infrastructure. This includes both routine and specialized tests that support personalized treatment approaches and improve long-term health outcomes.
The market is experiencing several trends, including a growing emphasis on strategic partnerships to drive innovation and an increase in funding for the development of advanced diagnostic technologies.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Provider Type
Market Breakup by Test Type
Market Breakup by End User
Hospital-Based Diagnostic Labs are Likely to Lead the Market Share by Provider Type
Segmentation based on the provider type consist of hospital-based diagnostic labs and standalone diagnostic labs. Hospital-based diagnostic labs are expected to dominate the market, primarily due to their integration with the overall healthcare system, larger patient access, and comprehensive services. A notable example is the collaboration between Fujifilm and Juntendo Hospital, announced in July 2024, to develop an AI system capable of predicting fall risks with 96% accuracy. This AI solution, which analyzes is designed to improve the identification of fall risks among outpatients. This advancement showcases how AI applications in hospital settings are driving the growth of diagnostic labs by enhancing patient care and enabling more precise, data-driven decisions. The involvement of hospitals in such innovations further supports their critical role in the diagnostic lab market, positioning them as the primary driver of advanced healthcare solutions in Japan.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Established in 1995, Agilus Diagnostics, is a key player in the market. Known for its comprehensive health diagnostics services, the company offers scientifically curated packages like the "Complete Care Vital," covering essential tests for inflammation, heart disease risk, and kidney health. With 400+ labs across 30 states, the company continues to expand its offerings, impacting Japan’s healthcare sector through accessible and reliable diagnostic solutions.
Labcorp, established in 1978 and headquartered in Burlington, North Carolina, is a global leader in life sciences, providing vital diagnostics and drug development services. In June 2022, the company expanded its operations in Japan through a collaboration with BML, a prominent local clinical laboratory provider. This strategic partnership, which involves the development of a new laboratory in Kawagoe, Saitama, aims to enhance clinical trial services and precision medicine capabilities. The expanded lab will offer advanced services like genomics, microbiology, and companion diagnostics, reinforcing Labcorp's presence in the Japan diagnostic lab market.
SRL Diagnostics, established in 1995 has significantly enhanced its presence in the diagnostic labs market through its Clinic Lab Management (CLM) model. This initiative involves SRL setting up and operating basic to medium diagnostic laboratories within clinics. Equipped with AI-powered pathology and radiology solutions, SRL delivers NABL and CAP-accredited diagnostics. With brands such as SRL Clinic, SRL Lifecare, and SRL Infotech, the company continues to drive innovation and accessibility in the diagnostic space, supporting hospitals and clinicians with automated, high-quality lab services.
LSI Medience Corporation, founded in 1975 and headquartered in Minato-ku, Tokyo, is a key player in Japan's diagnostic labs market, specializing in clinical testing services. In July 2024, LSI Medience entered a strategic partnership with ACT Genomics to integrate genomic profiling into clinical research, enhancing precision medicine in Japan. The collaboration leverages LSI Medience’s testing capabilities and ACT Genomics' expertise in cancer genomic profiling, aligning with Japan's evolving healthcare needs.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Quest Diagnostics, H.U. Group, and SHIMA Laboratories Co., Ltd.
Upto 15% Off
USD
$3099 $2789
$1999 $1799
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Provider Type |
|
| Breakup by Test Type |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share